Dr. Baas on the Standard of Care for Mesothelioma Patients

Video

Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients

Paul Baas, MD, PhD, thoracic oncologist in the Division of Medical Oncology of the Netherlands Cancer Institute in Amsterdam, discusses the standard of care for mesothelioma patients.

Baas describes the current standard, platinum with an antifolate, as successful at first but does not have long-term benefits beyond 2 years.

There are currently 2 phase III studies investigating mesothelioma treatment. The first study was presented at ASCO and failed to produce results. Another study that will be presented at ESMO looks at recurrent mesothelioma.

New treatments for mesothelioma are constantly being investigated because asbestos is still commonly used in third world countries that do not have any rules or regulations against its use.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,